Plaznik A, Stefanski R, Palejko W, Bidzinski A, Kostowski W, Jessa M, Nazar M
Department of Pharmacology and Physiology of the Nervous System, Institute of Psychiatry and Neurology, Warsaw, Poland.
Pharmacol Biochem Behav. 1994 Jun;48(2):315-25. doi: 10.1016/0091-3057(94)90533-9.
The effects of chronic administration of desipramine, citalopram, and electroconvulsive shocks (ECS) on changes in rat motility after intraaccumbens (NAS) injections of selective serotonergic drugs were studied in intact and 5.7-DHT lesioned animals. It was shown that local injections of 8-OHDPAT and DOI-HCl depressed rat locomotor activity. Their effects appeared to be mediated postsynaptically, and could be antagonized by NAN-190 and ritanserin, respectively. Chronic but not acute pretreatment of rats with antidepressants (21 days long; the experiment was performed 24 h after the last dose) as well as repeated ECS (shocks were applied five times every second day), antagonized behavioral depression after 8-OHDPAT and DOI-HCl. The influence of antidepressant treatment was prevented by serotonergic lesions. Chronic administration of antidepressants and ECS did not equivocally affect the levels or metabolism of 5-HT, dopamine, and noradrenaline in the rat limbic forebrain. It is concluded that the present data indicate diminished activity of 5-HT systems related to the 5-HT1A and 5-HT2 receptors in the limbic nucleus, after chronic antidepressant treatment. This effect of drugs and ECS concerns nervous processes linked with the function of postsynaptically localized 5-HT receptor subtypes, and it probably depends on intact presynaptic 5-HT innervation.
在完整和5,7 - 二氢麦角隐亭(5,7 - DHT)损伤的动物中,研究了长期给予地昔帕明、西酞普兰和电惊厥休克(ECS)对伏隔核(NAS)注射选择性5 - 羟色胺能药物后大鼠运动变化的影响。结果表明,局部注射8 - 羟基二丙胺基四氢吡啶(8 - OHDPAT)和盐酸DOI可抑制大鼠的自发活动。它们的作用似乎是通过突触后介导的,并且分别可被NAN - 190和利坦色林拮抗。用抗抑郁药对大鼠进行慢性(而非急性)预处理(为期21天;在最后一剂后24小时进行实验)以及重复给予ECS(每隔一天给予5次电击),可拮抗8 - OHDPAT和盐酸DOI引起的行为抑制。5 - 羟色胺能损伤可阻止抗抑郁药治疗的影响。长期给予抗抑郁药和ECS对大鼠边缘前脑5 - 羟色胺(5 - HT)、多巴胺和去甲肾上腺素的水平或代谢没有明确影响。得出的结论是,目前的数据表明,长期抗抑郁药治疗后,与边缘核中5 - HT1A和5 - HT2受体相关的5 - HT系统活性降低。药物和ECS的这种作用涉及与突触后定位的5 - HT受体亚型功能相关的神经过程,并且可能依赖于完整的突触前5 - HT神经支配。